Amifostine

ETHYOL 50 mg/ml POLVO PARA SOLUCION PARA PERFUSION

500 mg polvo para solución para perfusiónSpainWithdrawnAuthorised 31 Jan 1996

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

EthyolBrazil · Schering-Plough Produtos Farmacêuticos LtdaSame brand
EthyolBrazil · Mantecorp Indústria Química e Farmacêutica S.A.Same brand
EthyolBrazil · Merck Sharp & Dohme Farmaceutica Ltda.Same brand
Ethyol - PWS IV 500MG/VialCanada · 500 MG / VIAL · Powder For Solution · Medimmune Oncology, INC.Same brand
EthyolUnited States · 375MG/VIAL, 500MG/VIAL · injectable · Legacy PharmaSame brand
AmifostineUnited States · 500MG/VIAL · injectable · Sun PharmSame form

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Amifostine

ETHYOL 50 mg/ml POLVO PARA SOLUCION PARA PERFUSION

500 mg polvo para solución para perfusiónSpainWithdrawnAuthorised 31 Jan 1996

Product informationAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Packs

Pack	Code	Status
ETHYOL 50 mg/ml POLVO PARA SOLUCION PARA PERFUSION , 3 viales de 500 mg	686733

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Amifostine
Strength: 500 mg
Dosage form: polvo para solución para perfusión
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Withdrawn
Status in the register: Revocado
Authorised: 31 Jan 1996
Registration: 60650
Marketing authorisation holder: Clinigen Healthcare B.V.
Procedure: National, MRP or DCP
Supply: Uso Hospitalario